2‐Amino‐3‐cyano‐4‐(5‐arylisoxazol‐3‐yl)‐4H‐chromenes: Synthesis and In Vitro Cytotoxic Activity

doi:10.1002/ardp.201100345

Paper

2‐Amino‐3‐cyano‐4‐(5‐arylisoxazol‐3‐yl)‐4H‐chromenes: Synthesis and In Vitro Cytotoxic Activity

Published May 1, 2012 · T. Akbarzadeh, A. Rafinejad, Javad Malekian Mollaghasem

Archiv der Pharmazie

44

Citations

0

Influential Citations

Full text

Abstract

A new series of 4‐aryl‐4H‐chromenes bearing a 5‐arylisoxazol‐3‐yl moiety at the C‐4 position were prepared as potential anticancer agents. The in vitro cytotoxic activity of the synthesized compounds was investigated against a panel of tumor cell lines including MCF‐7 (breast cancer), KB (nasopharyngeal epidermoid carcinoma), Hep‐G2 (liver carcinoma), MDA‐MB‐231 (breast cancer), and SKNMC (human neuroblastoma) using the MTT colorimetric assay. Doxorubicin, a well‐known anticancer drug, was used as positive standard drug. Among the synthesized compounds, the 5‐(3‐methylphenyl)isoxazol‐3‐yl analog (7j) showed the most potent cytotoxic activity against all five human tumor cell lines.

In Vitro Study

Study Snapshot

The 5(3methylphenyl)isoxazol-3yl analog (7j) showed the most potent cytotoxic activity against all five human tumor cell lines, suggesting potential anticancer activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

2‐Amino‐3‐cyano‐4‐(5‐arylisoxazol‐3‐yl)‐4H‐chromenes: Synthesis and In Vitro Cytotoxic Activity

References

Citations